Dashboard
Manage Tickers

REPL Replimune Group, Inc.

Nasdaq replimune.com


$ 8.93 $ 0.03 (0.39 %)    

Thursday, 13-Nov-2025 13:03:37 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 609.38 $ -8.30 (-1.34 %)
DIA $ 477.68 $ -3.68 (-0.76 %)
SPY $ 674.20 $ -6.28 (-0.92 %)
TLT $ 89.66 $ -0.14 (-0.16 %)
GLD $ 386.50 $ -0.76 (-0.2 %)
$ 9.04
$ 8.87
$ 8.93 x 152
$ 8.94 x 165
$ 8.70 - $ 8.99
$ 2.68 - $ 17.00
3,489,295
na
709.13M
$ 0.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-22-2025 03-31-2025 10-K
4 02-12-2025 12-31-2024 10-Q
5 11-12-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-16-2024 03-31-2024 10-K
8 02-08-2024 12-31-2023 10-Q
9 11-07-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-18-2023 03-31-2023 10-K
12 02-09-2023 12-31-2022 10-Q
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-19-2022 03-31-2022 10-K
16 02-03-2022 12-31-2021 10-Q
17 11-04-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-20-2021 03-31-2021 10-K
20 02-04-2021 12-31-2020 10-Q
21 11-05-2020 09-30-2020 10-Q
22 08-07-2020 06-30-2020 10-Q
23 06-03-2020 03-31-2020 10-K
24 02-13-2020 12-31-2019 10-Q
25 11-12-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 06-28-2019 03-31-2019 10-K
28 02-14-2019 12-31-2018 10-Q
29 11-14-2018 09-30-2018 10-Q
30 08-30-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

replimune-presents-new-ignyte-trial-data-showing-rp1-plus-nivolumab-reverses-resistance-to-pd-1-blockade-and-delivers-durable-responses-in-advanced-melanoma
Replimune Presents New IGNYTE Trial Data S...
11/07/2025 21:49:40

Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immun...

replimune-group-q2-eps-090-misses-074-estimate
Replimune Group Q2 EPS $(0.90) Misses $(0....
11/06/2025 13:21:23

Replimune Group (NASDAQ:REPL) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0...

kimberly-clark-vertex-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Kimberly-Clark, Vertex And Other Big Stock...
11/03/2025 13:14:55

bmo-capital-upgrades-replimune-group-to-market-perform-raises-price-target-to-11
BMO Capital Upgrades Replimune Group to Ma...
11/03/2025 10:37:41

BMO Capital analyst Evan David Seigerman upgrades Replimune Group (NASDAQ:REPL) from Underperform to Market Perform and rais...

this-five-below-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Five Below Analyst Turns Bullish; Her...
10/27/2025 11:29:57

hc-wainwright--co-upgrades-replimune-group-to-buy-announces-12-price-target
HC Wainwright & Co. Upgrades Replimune Gro...
10/27/2025 11:21:03

HC Wainwright & Co. analyst Robert Burns upgrades Replimune Group (NASDAQ:REPL) from Neutral to Buy and announces $12 pr...

jp-morgan-upgrades-replimune-group-to-neutral-announces-11-price-target
JP Morgan Upgrades Replimune Group to Neut...
10/20/2025 22:01:07

JP Morgan analyst Anupam Rama upgrades Replimune Group (NASDAQ:REPL) from Underweight to Neutral and announces $11 price tar...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/20/2025 18:39:30

heres-why-replimune-group-repl-stock-is-up-over-100-today
Here's Why Replimune Group (REPL) Stock Is...
10/20/2025 16:14:07

Shares of Replimune Group are rising Monday after the clinical stage biotechnology company shared an important regulatory update.

leerink-partners-upgrades-replimune-group-to-outperform-raises-price-target-to-13
Leerink Partners Upgrades Replimune Group ...
10/20/2025 14:35:25

Leerink Partners analyst Jonathan Chang upgrades Replimune Group (NASDAQ:REPL) from Market Perform to Outperform and raises ...

ww-international-replimune-group-datavault-ai-grail-and-other-big-stocks-moving-higher-on-monday
WW International, Replimune Group, Datavau...
10/20/2025 14:13:22

dow-jumps-over-200-points-cleveland-cliffs-shares-jump-after-q3-results
Dow Jumps Over 200 Points; Cleveland-Cliff...
10/20/2025 13:49:54

wedbush-upgrades-replimune-group-to-outperform-raises-price-target-to-18
Wedbush Upgrades Replimune Group to Outper...
10/20/2025 13:09:45

Wedbush analyst Robert Driscoll upgrades Replimune Group (NASDAQ:REPL) from Neutral to Outperform and raises the price targe...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

Core News & Articles
Market-Moving News for October 20th
10/20/2025 11:36:19

REPL: 81% | The FDA Accepts Replimune's Resubmission Of The Biologics License Application For RP1 In Combination With Nivol...

the-fda-accepts-replimunes-resubmission-of-the-biologics-license-application-for-rp1-in-combination-with-nivolumab-for-advanced-melanoma-pdufa-date-is-april-10-2026
The FDA Accepts Replimune's Resubmission O...
10/20/2025 11:07:36

replimune-group-option-alert-oct-17-6-calls-sweep-16-near-the-ask-1346--025-vs-129-oi
Replimune Group Option Alert: Oct 17 $6 Ca...
09/29/2025 18:27:43

this-united-parcel-service-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-friday
This United Parcel Service Analyst Is No L...
09/19/2025 12:06:21

jp-morgan-downgrades-replimune-group-to-underweight
JP Morgan Downgrades Replimune Group to Un...
09/19/2025 11:39:42

JP Morgan analyst Anupam Rama downgrades Replimune Group (NASDAQ:REPL) from Neutral to Underweight.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 17:06:02

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION